Impact of Metabolic Syndrome on Rehabilitation Outcomes in Rotator Cuff Injury

N/AActive Not RecruitingNCT06946472

Elif Dilara Durmaz40 enrolled

Overview

This prospective comparative study aims to investigate the effect of Metabolic Syndrome (MetS) on the outcomes of a standardized rehabilitation program in patients with Rotator Cuff Injuries (RCI). Patients diagnosed with RCI will be divided into two groups based on the presence or absence of MetS, determined by NCEP-ATP III criteria. Both groups will receive the same 4-week physiotherapy protocol including hot pack, TENS, ultrasound, and therapeutic exercises. Pain intensity, pain threshold, muscle strength, kinesthesia, and shoulder functionality will be evaluated before and after treatment. The study hypothesizes that the presence of MetS negatively affects rehabilitation outcomes in patients with RCI by altering inflammation and tissue healing processes.

This study aims to investigate the differences in shoulder function and rotator cuff tear outcomes between individuals with and without Metabolic Syndrome (MetS). Participants will be divided into two groups: the MetS group, which meets at least three of the NCEP-ATP III criteria for Metabolic Syndrome, and the non-MetS group, which does not have MetS. Both groups will undergo an initial assessment, focusing on shoulder function, rotator cuff tear status, and associated factors such as age, gender, and general health conditions. The study will explore how MetS may impact the recovery and function of the shoulder in individuals with rotator cuff tears, aiming to provide insights into potential treatment and rehabilitation strategies for this population. Data will be collected at a single time point (cross-sectional study) to evaluate baseline conditions and differences between the two groups. Statistical analyses will be performed to compare outcomes and explore potential correlations with MetS criteria.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Rotator Cuff Injury (RCI)Metabolic Syndrome (MetS)

Eligibility

Sex: ALLMin age: 18 YearsMax age: 65 Years

Medical Language ↔ Plain English

* Inclusion Criteria for the Non-MetS Group: * Aged between 18-65 years * Willing to participate in the study * Unilateral Rotator Cuff Tear (RMY) * Inclusion Criteria for the MetS Group: In addition to the above criteria, meeting at least three of the NCEP-ATP III consensus criteria for Metabolic Syndrome Stable metabolic syndrome (e.g., no significant medical changes in the last 3 months) \- Exclusion Criteria for All Participants: * Inability to cooperate with the tests or presence of mental health issues * Presence of cervical radiculopathy symptoms * Presence of other orthopedic pathologies in the same shoulder (e.g., fracture, prosthesis, avascular necrosis, advanced shoulder osteoarthritis, frozen shoulder, severe scapular dyskinesia, neurological diseases, etc.) * Presence of function-limiting neurological, vascular, or cardiac issues * Local steroid injection to the shoulder within the last 3 months * Receipt of physiotherapy or rehabilitation within the last 3 months * Systemic rheumatic or inflammatory diseases * Surgical history due to chronic rotator cuff tear * Diagnosis of glenohumeral joint or acromioclavicular joint arthritis * Severe scapular dysfunction or significant postural abnormalities

Outcomes

Primary Outcomes

Change in Shoulder Pain Severity (Visual Analog Scale - VAS)

Pain severity will be assessed in individuals with Myofascial Pain Syndrome (MPS) affecting the shoulder using the Visual Analog Scale (VAS). The VAS is a 10 cm horizontal line where 0 indicates "no pain" and 10 indicates "worst imaginable pain." Participants will be asked to rate their pain both at rest and during common daily activities (e.g., lifting the arm, brushing hair, dressing, reaching). Measurements will be conducted twice: once before the treatment (baseline) and once after the intervention period to evaluate changes in pain intensity.